FOCUSON™ FOR NEUROLOGY
Monitoring and triaging service for your cryptogenic stroke patients
FOCUSON™ + REVEAL LINQ™ ICM
WHY USE REVEAL LINQ™ FOR CRYPTOGENIC STROKE MONITORING?
- Atrial fibrillation (AF) is a common arrhythmia that may be the origin of a stroke
- Patients with AF have a five-fold increased stroke risk1
- Continuous monitoring reveals AF in about 30% of cryptogenic stroke patients and is superior to standard of care for the detection of AF2
- 88% of patients who had AF would have been missed if only monitored for 30 days2*
CRYSTAL AF STUDY RESULTS
- Reveal™ ICM is superior to standard monitoring for AF detection in cryptogenic stroke patients2
- 30 days of monitoring is not enough for AF detection in cryptogenic stroke2
- Reveal LINQ™ ICM System transforms your ability to diagnose AF with its proven AF detection algorithm
- With up to 3 YEARS of continuous cardiac monitoring
2016 ESC Atrial Fibrillation GUIDELINES3
LONG-TERM CARDIAC MONITORING RECOMMENDED FOR CRYPTOGENIC STROKE PATIENTS
- The ESC guidelines for the management of atrial fibrillation recommends long-term monitoring in patients with cryptogenic stroke
- Developed by the European Society of Cardiology (ESC) together with the European Heart Rhythm Association (EHRA)
- These guidelines are endorsed by the European Stroke Organisation (ESO)
|IIa||B||In stroke patients, additional ECG monitoring by long-term non-invasive ECG monitors or implanted loop recorders should be considered to document silent atrial fibrillation3.|
Barrier – reliance on Cardiology
- All raw ECG data needs to be interpreted by the cardiology department within the hospital
SOLUTION – FOCUSON™
- Expertise in ECG analysis
- Focus on the 20% that matters4
WHAT IS FOCUSON™?
FOCUSON™ is a monitoring and triaging service designed to help healthcare professionals save time whilst enabling better outcomes.
Our aim is simple: we want to help hospital clinical teams focus on the clinically actionable events transmitted by their patients, which represents just 20% of the total.4
To achieve this, thanks to the cardiac expertise of the FOCUSON™ team, the incoming data is monitored, triaged and reported according to clinic preference: turning cardiac data into timely, actionable insights.
The continuous FocusOn™ process
Remote monitoring of patients
The CareLink™ Network receives data from patients with Medtronic implantable cardiac devices.
Monitoring and triaging service
The FOCUSON™ team monitors and triages all incoming CareLink™ data according to hospital customisations. The hospital clinical teams are then alerted about clinically actionable events via telephone, email and the FOCUSON™ Platform.
Hospital clinical teams
Teams are promptly alerted on urgent information, so they have more time to spend with patients and with those that need immediate care.
FOCUSON™ analysis performed by a highly skilled and experienced team of ECG technicians.
Prompt communication of clinically relevant events enables swift actions to treat patients.
Prioritised and proactive communication frees up resources, so more patients can be seen and treated.
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly.
The Framingham Study. Arch Intern Med. September 1987;147(9):1561-1564.
- Sanna T, Diener HC, Passman RS, et al. Cryptogenic Stroke and Underlying Atrial Fibrillation.
N Engl J Med. 2014;370:2478-2486.
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 Aug 27. pii: ehw210.
- Medtronic data on file from more than 500 patients monitoried and triaged.
*Based on Kaplan Meier estimates.
See the MRI SureScan® manual before performing an MRI Scan and the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.com.